Ticker Scorecard - TGTX Basics Company: TG Therapeutics, Inc. IPO Date: June 1, 2010 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 3.21% Avg Daily Range (30 D): $0.63 | 2.05% Avg Daily Range (90 D): $0.82 | 2.74% Institutional Daily Volume Avg Daily Volume: 1.63M Avg Daily Volume (30 D): 1.71M Avg Daily Volume (90 D): 2.22M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 5,016 Avg Inst. Trade: $2.66M Avg Inst. Trade (30 D): $3.19M Avg Inst. Trade (90 D): $3.48M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.49M Avg Closing Trade (30 D): $7.3M Avg Closing Trade (90 D): $8.84M Avg Closing Volume: 262.91K     News Nov 29, 2024 @ 1:00 PM TG Therapeutics to Participate in the Evercore Hea... Source: N/A Nov 21, 2024 @ 11:00 AM TG Therapeutics Ranked Number One Fastest-Growing ... Source: N/A Jun 27, 2024 @ 5:55 PM "Rule Breaker Investing" Market Cap Game Show: Bil... Source: newsfeedback@fool.com (Motley Fool Staff) Jun 7, 2024 @ 11:50 AM TG Therapeutics to Participate in the Goldman Sach... Source: TG Therapeutics, Inc. Jun 3, 2024 @ 11:30 AM TG Therapeutics to Participate in the Jefferies Gl... Source: TG Therapeutics, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.1 $.03 $.05 Diluted EPS $-.11 $.02 $.04 Revenue $ 264.79M $ 83.88M $ 73.47M Gross Profit $ 233.85M $ 74.54M $ 65.16M Net Income / Loss $ -14.36M $ 3.88M $ 6.88M Operating Income / Loss $ -.51M $ 12.43M $ 8.82M Cost of Revenue $ 30.94M $ 9.34M $ 8.3M Net Cash Flow $ 44.93M $ 112.92M $ 7.44M PE Ratio     Splits Apr 30, 2012:   281:5 Jul 14, 2011:   50:1 Sep 25, 2003:   5:1